David Reese Selected Research

David Reese Research Topics

4	Breast Neoplasms (Breast Cancer) 05/2004 - 08/2002
3	Neoplasms (Cancer) 04/2013 - 08/2002
1	Parkinson Disease (Parkinson's Disease) 04/2024
1	Movement Disorders (Movement Disorder) 01/2022
1	Liver Failure 01/2022
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Cough 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Lung Injury 01/2018
1	Bronchopneumonia 01/2018
1	Pneumothorax 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2010
1	Pleural Effusion (Pleural Effusions) 03/2010
1	Disease Progression 05/2004
1	Neutropenia 10/2002
1	Febrile Neutropenia 10/2002
1	Uterine Hemorrhage (Uterine Bleeding) 09/2002
1	Weight Gain 09/2002

2	Carboplatin (JM8)FDA LinkGeneric 03/2010 - 05/2004
2	Trastuzumab (Herceptin)FDA Link 05/2004 - 08/2002
2	Docetaxel (Taxotere)FDA Link 05/2004 - 10/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2002 - 08/2002
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	IronIBA 01/2022
1	Monoclonal AntibodiesIBA 04/2013
1	Panitumumab (Vectibix)FDA Link 04/2013
1	ErbB Receptors (EGF Receptor)IBA 04/2013
1	Bevacizumab (Avastin)FDA Link 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2010
1	human TNFSF10 proteinIBA 03/2010
1	PlatinumIBA 05/2004
1	SaltsIBA 05/2004
1	Cisplatin (Platino)FDA LinkGeneric 05/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2002
1	myelopoietinIBA 10/2002
1	Filgrastim (Neupogen)FDA Link 10/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2002
1	leridistimIBA 10/2002
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2002
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2002
1	EnzymesIBA 09/2002
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2002
1	Aromatase (CYP19)IBA 09/2002
1	Tamoxifen FDA LinkGeneric 09/2002
1	Anastrozole (Arimidex)FDA LinkGeneric 09/2002
1	AnthracyclinesIBA 08/2002
1	Proteins (Proteins, Gene)FDA Link 08/2002
1	Methotrexate (Mexate)FDA LinkGeneric 08/2002
1	Fluorouracil (Carac)FDA LinkGeneric 08/2002
1	Taxoids (Taxanes)IBA 08/2002